Different routes bridging calcium in Japanese hemodialysis patients

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Mineral Metabolism

Background:

• Excessive calcium load, not just serum calcium, is linked to vascular calcification and mortality in hemodialysis patients.
• Calcium accumulates from oral intake (phosphate binders), dialysate, and vitamin D therapy.
• Current K/DOQI guidelines suggest sevelamer hydrochloride over calcium-based phosphate binders.

Purpose of the Study:

• To discuss the appropriate dialysate calcium concentration (D-Ca) for Japanese hemodialysis patients.
• To evaluate the impact of different D-Ca levels and phosphate binders on calcium load and patient outcomes.
• To inform comprehensive management strategies in light of new K/DOQI guidelines.

Main Methods:

• Review of current practices regarding phosphate binders and D-Ca in Japan.
• Analysis of the physiological effects of different D-Ca concentrations (3.0 vs. 2.5 mEq/L) on calcium balance and parathyroid hormone levels.
• Consideration of sevelamer-associated adverse events in the Japanese population.

Main Results:

• 3.0 mEq/L D-Ca may promote metastatic calcification due to post-hemodialysis phosphate rebound.
• 2.5 mEq/L D-Ca might lead to increased intact parathyroid hormone, especially with reduced oral calcium intake.
• Hypercalcemia is less likely with 2.5 mEq/L D-Ca, despite potentially higher vitamin D requirements.

Conclusions:

• The choice of D-Ca and phosphate binders significantly impacts calcium load in Japanese hemodialysis patients.
• Balancing phosphate control, calcium load, and vitamin D therapy is essential for preventing vascular calcification and mortality.
• Individualized management strategies considering patient-specific factors and regional practices are recommended.